Keyphrases
Type 2 Diabetic Patients
83%
Insulin Secretion
77%
C-peptide
75%
Glucose-tolerant
75%
HNF1A
72%
First-degree Relatives of Type 2 Diabetics
72%
Polymorphism
70%
C-peptide Response
50%
Oral Glucose Tolerance Test
50%
Amino Acid Variation
48%
Proband
43%
Insulin Sensitivity
39%
Intravenous Glucose
36%
Overweight Adults
36%
K121Q
36%
PC-1
36%
Cell Function
36%
Pancreatic Cells
36%
Non-diabetic
36%
Liraglutide
36%
Glycemic Control
36%
IRS2
36%
Encoding Sequence
36%
Type I Diabetes
36%
Adult Patients
36%
Randomized Placebo-controlled Trial
36%
Family Members
36%
Genetic Correlation
36%
Tolbutamide
36%
Phosphotyrosine
36%
Type 1 Diabetes Mellitus (T1DM)
36%
Inter-individual Variation
36%
Gene Promoter
36%
Heritability
36%
Serum Insulin
36%
Placebo
21%
Type 2 Diabetic
19%
Codon
17%
Middle-aged
16%
B Cells
15%
Biochemistry, Genetics and Molecular Biology
Glucose Tolerance Test
100%
Glucose Test
100%
C-Peptide
84%
Insulin Release
83%
Insulin Blood Level
75%
Hepatocyte Nuclear Factor 1
72%
Insulin Sensitivity
69%
Proband
58%
Amino Acid
50%
Insulin Receptor
45%
Tolbutamide
45%
Gene Frequency
42%
Insulin Resistance
42%
Offspring
37%
Gene Promoter
36%
Genetic Correlation
36%
Cell Function
36%
Insulin-Like Growth Factor 1 Receptor
36%
Insulin-Like Growth Factor 1
30%
Normal Human
27%
Codon
25%
Promoter Region
21%
Wild Type
21%
Blood Plasma
18%
Population Research
16%
Immunology and Microbiology
Insulin Release
72%
Insulin
43%
Insulin Sensitivity
42%
Glycemic Control
36%
Heritability
36%
Genetic Correlation
36%
Insulin Receptor
36%
Gene Promoter
36%
Promoter Region
21%
Insulin Blood Level
20%
Glucagon-Like Peptide-1
20%
